Guolian Securities logo

Guolian Securities

Asia, Anhui, China, Wuxi

Description

Guolian Securities provides various financial products and services in the People’s Republic of China.

Investor Profile

Guolian Securities has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series D rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Advanced Materials, Manufacturing, Biotechnology.

Stage Focus

  • Series A (50%)
  • Series D (50%)

Country Focus

  • China (100%)

Industry Focus

  • Advanced Materials
  • Manufacturing
  • Biotechnology
  • Health Care
  • Oncology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Guolian Securities frequently co-invest with?

TriWise Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
WuXi Healthcare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
GLP Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 1
SDIC Fund Management
Asia, Beijing, China, Beijing
Co-Investments: 1
Huaneng Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Investments: 1
Tiange Interactive Holdings
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Legend Star
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Investments: 1
Tigermed
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1

What are some of recent deals done by Guolian Securities?

Riyu Photovoltaic

Wuxi Shi, Jiangsu, China

Riyu Photovoltaic specializes in the development of solar cell front silver paste materials.

Advanced MaterialsManufacturing
Series AAug 27, 2023
Amount Raised: $13,717,421
Adlai Nortye

Hangzhou, Zhejiang, China

Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.

BiotechnologyHealth CareOncologyPharmaceutical
Series DJul 13, 2021
Amount Raised: $100,000,000